Clinical Trial

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Recruiting
View on ClinicalTrials.gov →
Summary
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-24; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2026-01-12
Trial Details
NCT Number NCT07204756
Lead Sponsor University of Minnesota
Conditions Postpartum, Hypertension, Hypertensive Disorder of Pregnancy
Enrollment 400 participants
Start Date 2026-01-07
Primary Completion 2028-01-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-14